Partial Protective Effect of Bivalent Human Papillomavirus 16/18 Vaccination Against Anogenital Warts in a Large Cohort of Dutch Primary Care Patients

P.J. Woestenberg*, A.E.G. Morel, J.A. Bogaards, M. Hooiveld, T.M. Schurink-van't Klooster, C.J.P.A. Hoebe, M.A.B. van der Sande, B.H.B. van Benthem

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)291-297
Number of pages7
JournalClinical Infectious Diseases
Volume73
Issue number2
DOIs
Publication statusPublished - 15 Jul 2021

Keywords

  • human papillomavirus
  • bivalent HPV vaccine
  • anogenital warts
  • vaccine effectiveness
  • cross-protection
  • HPV-16/18 AS04-ADJUVANTED VACCINE
  • GENITAL WARTS
  • CROSS-PROTECTION
  • CERVICAL-CANCER
  • HPV TYPES
  • BURDEN
  • IMPACT
  • WOMEN
  • POSITIVITY
  • PREVENTION

Cite this